Citation: | Zhang FangXin, . The effect of intraarterial chemotherapy on t-cell subsets in patients with primary liver cancer[J]. Cancer Research on Prevention and Treatment, 1995, 22(2): 72-73. |
[1] |
细川真澄男.杭痛药物剂に对宿主レての免疫效果增强.Biotherapy, 1990, 4,1229
|
[2] |
Fernandez-Cruz E, Woda BA, Feldman JD. Elimination of syngeneic sarcomas in rats by a subsets of T lym-phacytes. J EXP Med, 1980, 152:823
|
[3] |
Ynh K, Shimiza M, Aoyama S, et al. Immunological analysis and characteraction of lymphocyte subsets in specimens of Kaman hepatocellular carcinoma and metastatic liver cancers. Cancer Immunol Immunother.1989, 28:131
|
[4] |
Claessen Anke M. E, Valster H, Bril H, et al. Cell-medited immunity is enhanced by cytostatic drugs con-tinaously released at the site of antigenic stimulation.Cancer Immunol Immunother, 1989, 28:131
|
[5] |
池田健次.肝细胞癌に对すね为肝动脉塞性术の细胞性免疫に及ほ影响すとその长期预后.肝脏,1989, 28:102
|
[6] |
三田地泰司,村川康子,奥野真,他.癌化学疗法施行患者の末梢血およひ肿启浸润りぃパ球サワモヅト痛と化学疗法,1990:482
|
[7] |
Onsrud M, Bosnea V , Grahm I. Cia-platinum as adjunc-five to surgery in early stage ovarian caricinomai effects on lymphoid cell subpopulation Gynecol Onml,1986,23.323
|
[8] |
Tsuru S,Shinomiya N,Kataura Y,et al. Effects of com-biped therapies with protein--bound polysaccharide and fluorimted pyrimidine derivatives on experimental liver metastases and on the immunologic capacities of the hosts. Oncology, 1991, 48,498
|
[9] |
Zielinski CC, Muller C, Kubista-E, et al. Elfecta of ad-juvant chemotherapy on specific and non-specific fm-mune mechanisms. Acta Med Austriaca, 1990, 17:II
|
[10] |
Graham P. J, Gee A, Emerson S, et al. Myeloabative chemoradiotherapy and autologous bone marrow infu-sions for treatment of neuroblastoma: factors inflaenc-ing engraftment. Blood, 1991, 78 } 1607
|